Immunosuppressive effect of tryptophan metabolites in composite tissue allotransplantation

Plastic and Reconstructive Surgery

Volumn 119, Issue 7, 2007, Pages 2023-2028

  Radu, Christian A ^b   Bosch, Nikolaus ^b   Bauer, Thomas M ^b   Kleist, Christian ^b   Jiga, Lucian ^b   Terness, Peter ^b   Opelz, Gerhard ^b   Gebhard, Martha M ^b   Germann, Guenter ^b   Baumeister, Steffen ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYANTHRANILIC ACID; DRUG METABOLITE; KYNURENINE; TACROLIMUS; TRYPTOPHAN DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; TRYPTOPHAN;

ALLOGRAFT; ANIMAL EXPERIMENT; ARTICLE; BROWN NORWAY RAT; CLINICAL OBSERVATION; COMPOSITE GRAFT; CONTROL GROUP; CONTROLLED STUDY; EXPERIMENTAL MODEL; GRAFT REJECTION; HINDLIMB; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LEWIS RAT; LOG RANK TEST; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TISSUE TRANSPLANTATION; ANIMAL; ANIMAL MODEL; DRUG EFFECT; INTRAMUSCULAR DRUG ADMINISTRATION; METABOLISM; TRANSPLANTATION;

3-HYDROXYANTHRANILIC ACID; ANIMALS; GRAFT REJECTION; HINDLIMB; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAMUSCULAR; KYNURENINE; MODELS, ANIMAL; RATS; RATS, INBRED LEW; TACROLIMUS; TISSUE TRANSPLANTATION; TRYPTOPHAN;

EID: 34249794883     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000260587.18762.a3     Document Type: Article

References (13)

1. Munn, D. H., Zhou, M., Attwood, J. T., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191, 1998.
2. Clark, D. A. Tolerance signaling molecules. Chem. Immunol. Allergy 89: 36, 2005.
3. Mellor, A. L., Chandler, P., Lee, G., et al. Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy. J. Reprod. Immunol. 57: 143, 2002.
4. Mellor, A. L., and Munn, D. H. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4: 762, 2004.
5. Fallarino, F., Grohmann, U., Vacca, C., et al. T cell apoptosis by tryptophan catabolism Cell Death Differ. 9: 1069, 2002.
6. Frumento, G., Rotondo, R., Tonetti, M., Damonte, G., Benatti, U., and Ferrara, G. B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J. Exp. Med. 196: 459, 2002.
7. Terness, P., Bauer, T. M., Rose, L., et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: Mediation of suppression by tryptophan metabolites. J. Exp. Med. 196: 447, 2002.
8. Bauer, T. M., Jiga, L. P., Chuang, J. J., Randazzo, M., Opelz, G., and Terness, P. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: Tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl. Int. 18: 95, 2005.
9. Mellor, A. L., and Munn, D. H. Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation? Immunol. Today 20: 469, 1999.
10. Morita, T., Saito, K., Takemura, M., et al. 3-Hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-gamma. Ann. Clin. Biochem. 38: 242, 2001.
11. Thomas, S. R., and Stocker, R. Antioxidant activities and redox regulation of interferon-gamma-induced tryptophan metabolism in human monocytes and macrophages. Adv. Exp. Med. Biol. 467: 541, 1999.
12. Freese, A., Swartz, K. J., During, M. J., and Martin, J. B. Kynurenine metabolites of tryptophan: Implications for neurologic diseases. Neurology 40: 691, 1990.
13. Moroni, F. Tryptophan metabolism and brain function: Focus on kynurenine and other indole metabolites. Eur. J. Pharmacol. 375: 87, 1999.